By Stephen Lin, PhD., CIRM Senior Science Officer A diabetic child is checking her blood sugar level (self glycaemia). Type 1 diabetes affects millions of people. It is a disease where beta islet cells in the pancreas are targeted by the body’s own immune system, destroying the ability to produce insulin. Without insulin, the body … Continue reading Scientists develop immune evading pancreas organoids to treat type 1 diabetes
Disease Areas
Stem Cell All-Stars, All For You
Dr. Larry Goldstein, UC San Diego It’s not often you get a chance to hear some of the brightest minds around talk about their stem cell research and what it could mean for you, me and everyone else. That’s why we’re delighted to be bringing some of the sharpest tools in the stem cell shed … Continue reading Stem Cell All-Stars, All For You
Scientists at UC Davis discover a way to help stem cells repair heart tissue
Researchers Phung Thai (left) and Padmini Sirish were part of a research team seeking stem cell solutions to heart failure care. Image Credit: UC Davis Repairing the permanent damage associated with a heart attack or long-term heart disease has been a challenge that scientists have been trying to tackle for a long time. Heart failure … Continue reading Scientists at UC Davis discover a way to help stem cells repair heart tissue
Therapy developed with CIRM award used in new clinical trial for COVID-19
Dr. Joshua Rhein, Assistant Professor of Medicine in the University of Minnesota Medical School's Division of Infectious Diseases and International Medicine Image Credit: University of Minnesota While doctors are still trying to better understand how to treat some of the most severe cases of COVID-19, researchers are looking at their current scientific "toolkit" to see if … Continue reading Therapy developed with CIRM award used in new clinical trial for COVID-19
Perseverance: from theory to therapy. Our story over the last year – and a half
Some of the stars of our Annual Report It’s been a long time coming. Eighteen months to be precise. Which is a peculiarly long time for an Annual Report. The world is certainly a very different place today than when we started, and yet our core mission hasn’t changed at all, except to spring into … Continue reading Perseverance: from theory to therapy. Our story over the last year – and a half
A new voice and vision added to CIRM Board
UC Davis School of Medicine Dean, Dr. Allison Brashear: Photo courtesy UCD We have a new member on the CIRM Board – Dr. Allison Brashear is the Dean of the UC Davis School of Medicine, overseeing one of the nation’s top research, academic and medical training institutions. Dr. Brashear is an internationally known researcher in … Continue reading A new voice and vision added to CIRM Board
CIRM progression award to support research towards immunodeficiency
Dr. Caroline Kuo, a member of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA In 2017, CIRM funded a discovery or early stage research project for Dr. Caroline Kuo at UCLA for a hereditary immune disorder known as X-Linked Hyper IgM Syndrome. The work has gone so well … Continue reading CIRM progression award to support research towards immunodeficiency
Celebrating a life that almost didn’t happen
Evie Vaccaro You can’t look at this photo and not smile. This is Evie Vaccaro, and it’s clear she is just bursting with energy and vitality. Sometimes it feels like I have known Evie all her life. In a way I have. And I feel so fortunate to have done so, and that’s why this … Continue reading Celebrating a life that almost didn’t happen
Encouraging news for treatment targeting retinitis pigmentosa
While most people probably wouldn’t put 2020 in their list of favorite years, it’s certainly turning out to be a good one for jCyte. Earlier this year jCyte entered into a partnership with global ophthalmology company Santen Pharmaceuticals worth up to $252 million. Then earlier this week they announced some encouraging results from their Phase … Continue reading Encouraging news for treatment targeting retinitis pigmentosa
CIRM Board Approves Two New Discovery Research Projects for COVID-19
Dr. Karen Christman (left) and Dr. Lili Yang (right) This past Friday the governing Board of the California Institute for Regenerative Medicine (CIRM) approved two new discovery research project as part of the $5 million in emergency funding for COVID-19 related projects. This brings the number of COVID-19 projects CIRM is supporting to 17, including three clinical trials. … Continue reading CIRM Board Approves Two New Discovery Research Projects for COVID-19
The Stem Cellar 